These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 15619237

  • 1. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
    Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS.
    Hepatology; 2005 Jan; 41(1):123-31. PubMed ID: 15619237
    [Abstract] [Full Text] [Related]

  • 2. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R, Singla V, Kacharya Sk.
    Trop Gastroenterol; 2008 Jan; 29(3):136-47. PubMed ID: 19115605
    [Abstract] [Full Text] [Related]

  • 3. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
    Bonnard P, Lescure FX, Amiel C, Guiard-Schmid JB, Callard P, Gharakhanian S, Pialoux G.
    J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
    [Abstract] [Full Text] [Related]

  • 4. Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients.
    Vergara S, Macías J, Mira JA, García-García JA, Merchante N, del Valle J, Abdel-Kader L, Lozano F, Gómez-Mateos JM, Pineda JA.
    J Antimicrob Chemother; 2007 Jan; 59(1):87-91. PubMed ID: 17095528
    [Abstract] [Full Text] [Related]

  • 5. Antiretroviral therapy based on protease inhibitors as a protective factor against liver fibrosis progression in patients with chronic hepatitis C.
    Macías J, Mira JA, López-Cortés LF, Santos I, Girón-González JA, González-Serrano M, Merino D, Hernández-Quero J, Rivero A, Merchante N, Trastoy M, Carrillo-Gómez R, Arizcorreta-Yarza A, Gómez-Mateos J, Pineda JA.
    Antivir Ther; 2006 Jan; 11(7):839-46. PubMed ID: 17302246
    [Abstract] [Full Text] [Related]

  • 6. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V, Puoti M, Mussini C, Bellelli S, Angeletti C, Sabbatini F, Prati F, Cossarizza A, Esposito R.
    Antivir Ther; 2008 Jan; 13(8):1057-65. PubMed ID: 19195331
    [Abstract] [Full Text] [Related]

  • 7. Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index.
    Kelleher TB, Mehta SH, Bhaskar R, Sulkowski M, Astemborski J, Thomas DL, Moore RE, Afdhal NH.
    J Hepatol; 2005 Jul; 43(1):78-84. PubMed ID: 15894397
    [Abstract] [Full Text] [Related]

  • 8. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
    Bani-Sadr F, Lapidus N, Bedossa P, De Boever CM, Perronne C, Halfon P, Pol S, Carrat F, Cacoub P, French National Agency for Research on AIDS, Viral Hepatitis-HC02-Ribavic Study Team.
    Clin Infect Dis; 2008 Mar 01; 46(5):768-74. PubMed ID: 18248298
    [Abstract] [Full Text] [Related]

  • 9. Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
    Sulkowski MS, Mehta SH, Torbenson MS, Higgins Y, Brinkley SC, de Oca RM, Moore RD, Afdhal NH, Thomas DL.
    AIDS; 2007 Oct 18; 21(16):2209-16. PubMed ID: 18090048
    [Abstract] [Full Text] [Related]

  • 10. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG, Monteiro M, Rehm J.
    Subst Use Misuse; 2006 Oct 18; 41(10-12):1395-463. PubMed ID: 17002989
    [Abstract] [Full Text] [Related]

  • 11. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
    Sánchez-Conde M, Berenguer J, Miralles P, Alvarez F, Carlos Lopez J, Cosin J, Pilar C, Ramirez M, Gutierrez I, Alvarez E.
    Clin Infect Dis; 2006 Sep 01; 43(5):640-4. PubMed ID: 16886160
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus-coinfected patients.
    Merchante N, Macías J, Ramayo E, Vergara S, García-García JA, Mira JA, Corzo JE, Gómez-Mateos JM, Lozano F, Pineda JA.
    J Viral Hepat; 2006 Jul 01; 13(7):449-56. PubMed ID: 16792538
    [Abstract] [Full Text] [Related]

  • 14. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.
    Clin Infect Dis; 2006 Apr 01; 42(7):1032-9. PubMed ID: 16511772
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. HIV and hepatitis C coinfection.
    Matthews GV, Dore GJ.
    J Gastroenterol Hepatol; 2008 Jul 01; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [Abstract] [Full Text] [Related]

  • 17. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
    Giordano TP, Kramer JR, Souchek J, Richardson P, El-Serag HB.
    Arch Intern Med; 2004 Nov 22; 164(21):2349-54. PubMed ID: 15557414
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.